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SUMMARY
Background: The aim of the study was to evaluate the effect of fungal colonization on the course of gastric ulcer
disease with particular regard to regression of clinical symptoms and reduction in ulcer niche size. 
Material and methods: The study was performed on the group of 293 patients, aged 20—80, with clinical symp-
toms of peptic ulcer disease, who attended Gastroenterology Outpatient Department of Collegium Medicum of
Krakw Jagiellonian University. Endoscopy of the upper gastrointestinal tract was performed before and follo-
wing a-4-week period of a standard anti-ulcerous treatment. During the examination aspirate of the stomach
contents and surface brushing were collected. Moreover, biopsy specimens from the bottom of the ulcer or infla-
med gastric mucosa were taken for mycological and histopathological examinations. According to contempora-
ry recommendations eradication treatment of Helicobacter pylori was introduced in urease-positive patients
with endoscopy-proved gastric ulcer. 
Results and conclusions: The results of our research showed that fungal colonization of gastric ulcers impairs
the course of ulcer healing. Moreover, it results in clinical symptoms maintenance as compared with ulcers with
non-significant fungal cells count.
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BACKGROUND
Interest in the involvement of infectious factors in
the pathogenesis of stomach and duodenum dise-
ases have grossly increased over recent years. So-
me years ago, acidic environment of stomach was
considered as an unfavourable factor for coloniza-
tion of gastric mucosa by both bacteria and fungi.
What is more presence of those organisms was re-
garded as an indicator of a decreased acidity of ga-
stric contents [1,2]. Fungi of Candida sp. represent
a component of normal flora of alimentary tract.
They were discovered in oral cavity, jejunum and
ileum in 30%, 54% and 55% of healthy people re-
spectively [3,4]. Nevertheless, results of contempo-
rary investigations indicate an increase in the inci-
dence of fungal colonization of gastric mucosa.
Fungi are isolated from patients without fungal in-
fection symptoms in 7 up to 33% of cases, accor-
ding to different authors [5,6,7].
Since 1980 many authors have underlined the fact
that fungal infections are on the increase [8]. At
present fungi represent one of the etiologic factors
of the hospital inborn infections. In the intensive
care units they are on the fourth place as regards
incidence [9].
Factors predisposing to the development of fungal
infections include underlying diseases such as dia-
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betes, neoplasm as well as surgery, injury, burn,
antibiotics, steroids, immunosuppressive agents or
cytostatic treatment. Moreover, parenteral nutri-
tion, intravascular or bladder catheter applied for
long predispose to fungal infection [5,10—12].
Candidiasis is still the most frequent mycosis of ali-
mentary tract and Candida albicans is isolated in
about 79% of cases [13]. Recently, a change in the
incidence of some species has been observed:
a decrease in C. albicans frequency and an incre-
ase in the frequency of previously rarely encounte-
red or totally absent species such as C. glabrata, C.
lusitaniae, C. krusei, C. zeylanoydes [14]. The fre-
quency of C. tropicalis has remained unchanged
[14]. A growth in mixed type infections incidence
has also been reported, even in up to 75% of ca-
ses, usually with C. albicans or C. tropicalis along
with C. krusei and C. glabrata involved [14]. The
reason for that is introduction of improved, more
sensitive diagnostic methods including DNA analy-
sis as well as immunosuppresive treatment and
broad application of wide-spectrum antibiotics [8].
This phenomenon was observed even when anti-
fungals of the imidazole group, e.g. fluconazole,
were applied [14]. These drug promoted growth of
C. krusei and C. glabrata which were already resi-
stant to fluconazole and cross resistant to other
agents of the imidazole group. The resistance to
antifungal agent was manifested by the lack of di-
sease regression but and intensification of clinical
symptoms during treatment [14].
Fungal colonization of gastric mucosa can be defi-
ned as presence of fungus in a symptom-free patient
[17]. It can develop into a fungal infection manife-
sted by infection symptoms and the presence of fun-
gal antigen in blood serum [17]. Candidemia i.e.
presence of fungi in the blood, is a result of a shift in
the equilibrium between the immune mechanisms
of host, like non-specific immunisation, cellular and
humoral resistance on the one hand and pathogeni-
city of invading strain and complex interactions be-
tween microorganisms on the other [18]. According
to Dyess, disturbance in defence mechanisms is the
main reason for candidemia. [13].
Clinical symptoms of fungal colonization of sto-
mach are rather non-specific. Dyspepsia, pain in
the epigastrium, weight loss, ulcerous sufferings
and vomiting are the most common. Sometimes,
bleeding from the upper part of alimentary tract re-
sulting from injury of a vessel by fungal infiltration
can occur [2,19].
Minoli et al. distinguished 3 basic types of endo-
scopic images in patients with fungal colonization
of gastric mucosa. The aphthous type, accounting
for 42% of all cases, is the easiest to identify as
white-grey membranes on a pulpy base. The nodu-
lar type, accounting for 27%, is usually found in
antrum as a-few-millimetre nodules surrounded by
inflammatory mucosa and granulation. This form of
candidiasis is often invasive. The ulcerous type was
found in 27% of all cases [21,22].
According to Loffeld and Antonioli, endoscopic
images of gastric ulcer infected with fungi have the
following features: the diameter of ulceration exce-
eding 2 cm, large crater with irregular infiltration of
the margins, hard bottom, tendency to bleed and
is localised in the area of the stomach angle [23].
Infiltrations consisting of neutrophiles, granulation
with giant cells, microabscesses and fibrin were fo-
und in the fungal ulcers [24]. The phenomenon of
dimorphism, i.e. concurrent presence of blastospo-
res and mycelium is considered as an indicator of
fungi pathogenicity [23,24].
In the late 1970s Robin Warren, histopathologist
from the Royal Perth Hospital in Australia, obse-
rved spiral bacteria in an active chronic gastritis B.
Since that time many research centers have confir-
med that spiral bacteria not only colonize gastric
mucosa but also cause chronic gastritis and appear
to be a substantial etiologic factor in gastric and
duodenal ulcer disease [1,26].
H. pylori infection increases the risk of gastric ulcer
and chronic gastritis development. The risk of ga-
stric ulcer is 3 to 10-folds higher and of gastric car-
cinoma twofold higher in patients with H. pylori
without symptoms of mucosa atrophy. Atrophy ra-
ises that risk twofold [27].
Gastric ulcer often develops from chronic atrophic
gastritis, which usually starts in the area of stomach
angle and is accompanied by intestinal metaplasia.
As a result a decrease in the secretion of hydro-
chloric acid in the stomach is observed [28,29].
Plasmacytic and lymphocytic infiltrations are typi-
cal for chronic gastritis in the course of H. pylori in-
fection and the presence of neutrophiles is an indi-
cator of the level of the process intensity [30].
Both spiral bacteria and fungi have been found in
the stomach environment. These microorganisms
are able to colonize gastric mucosa. According to
some authors, e.g. Lee et al, fungi are regarded as
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’innocent bystanders’, which under favourable con-
ditions can lead to inflammatory reaction [30,31].
Fungi have been found mostly at the bottom of the
ulceration and in its vicinity [30]. Spiral bacteria are
present in both antrum and the body of the sto-
mach. Gastritis caused by that bacterium is a pro-
gressive process, which starts in antrum and spre-
ads into the body of the stomach. Subsequently
this process leads to atrophic changes in mucosa
[32,33,34]. Infiltrations consisting of plasmocytes
and neutrophiles are indicators of the inflammatory
process. The presence of neutrophiles is a measure
of its intensity. However, infiltrations of neutrophi-
les, granulation with giant cells, microabscesses
and fibrin are found at the bottom of gastric ulcers
colonised by fungi. The importance of fungi occur-
rence in gastric environment seems to be an open
question, which requires a more detailed explana-
tion, regardless the role of spiral bacteria in the pa-
thogenesis of gastric and duodenal disorders.
The objectives of this investigation were as follows:
— to determine the incidence of fungi in the sto-
mach of patients with gastric ulcer and chronic
gastritis compared to healthy population;
— to determine the effect of fungal colonization on
the course of gastric ulcer disease, with particular
regard to regression of clinical symptoms and re-
duction in ulcerous niche size.
MATERIAL AND METHODS
The study was performed on a group of 293 pa-
tients including 142 females and 151 males, aged
20—80, with dyspeptic complaints or clinical symp-
toms of peptic ulcer disorder, attending Gastroen-
terology Outpatient Department of Collegium Me-
dicum of Krakw Jagiellonian University. The full
characterics is presented in Table 1.
Patients with diabetes and systemic diseases as well
as those taking cytostatics, steroids, antibiotics or
non-steroid drugs within 6 weeks preceding the
study were excluded. Before entering the study all
patients gave their written informed consent.
Clinical examinations 
Clinical examinations included full medical history
with a special focus on the duration of the disease,
drugs ingested, use of stimulants (tobacco, alcohol,
coffee) and involvement of other factors promoting
development of mycosis [13]. Gastric contents, sur-
face brushing from the bottom of ulcer or from in-
flamed gastric mucosa and biopsy specimens from
the bottom of the ulcer or from inflamed gastric
mucosa were sampled from all patients for mycolo-
gical examinations.
The pH of gastric contents aspirate was measured
in all patients.
On endoscopy, biopsy specimens from the vicinity
of the ulcer or inflammatory gastric mucosa (in-
flammation criteria by The World Congress of Ga-
stroenterology in Sydney, 1990) and from prepylo-
ric area [37] were taken for a routine histopatholo-
gical examination. The presence of spiral bacteria
and fungi was also checked.
After every examination, special attention was paid
to precise cleaning and disinfection of the endo-
scop, bioptic forceps and cannulas for gastric con-
tents, according to the guidelines of the European
Society of Endoscopy [38].
Blood samples were collected from all patients for
blood grouping and to determine the level of fun-
gal antibodies in serum. Moreover, in 51 patients
the presence of fungal mannan antigen was deter-
mined.
Mycological examination 
Mycological examination included evaluation of di-
rect specimens from the aspirated gastric contents
and surface brushing collected from the bottom of
Group N Number of women Number of men Age* of women Age* of men
Gastric ulcer with significant fungal cells count
Gastric ulcer with non-significant fungal cells count
Chronic gastritis
Control
N — group size, * — mean, minimum and maximum ages are given in years.
51
43
107
92
26
20
61
35
25
23
46
57
55  33—70
48  27—70
50  23—73
43  20—69
56  36—70
50  36—70
48  21—70
48  21—80
Table 1. Profile of investigated groups.
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the ulcer or inflamed mucosa. Also, quantitative
and qualitative examinations of gastric contents,
surface brushing and biopsy specimens sampled
from the bottom of ulceration or inflamed mucosa
were performed, including identification of cultu-
red strains and antimicograms.
Quantitative mycological examinations and results
analyses were performed by modified M(ller me-
thod [39]. According to this method, the fungal
cells count of 103 cells/ml and below was conside-
red as a non-significant. The result of 104 cells/ml
was considered as ambiguous requiring re-exami-
nation. The results of 105 and 106 cells/ml were re-
garded as significant count of fungal cells in the
examined specimen.
Further identification of Candida and Torulopsis
species was performed using biochemical tests API
20C AUX (bioM(rieux, France), according to the
procedure recommended by manufecturer.
Susceptibility of fungi, isolated from patients, to an-
tifungal drugs was determined by diffusion-disk
method with the use of standard paper disks What-
man 3 mm Chr soaked with antifungal drugs.
The serological examination included the detection
of IgG antifungal antibodies in blood serum by in-
direct immunofluorescence reaction and immuno-
diffussion in gel [39]
In order to detect fungal mannan antigen in blood
serum latex test of Latex Detection System (Immu-
no-Mycologics Inc, USA) was applied.
Also, in vitro examinations of the growth of 71 C.
tropicalis and 24 C. albicans strains, isolated from
patients, in Sabouraud medium at pH from 2.0 to
8.0 were carried out. The obtained results repre-
sented the basis to determine typical pH for the
growth of fungal strains studied.
As a result of endoscopic and mycological exami-
nations, the patients were divided into the groups
such as:
a) Patients with gastric ulcer and significant count
of fungal cells in the stomach in whom the count
of fungal cells was 105 cells/ml or higher in at le-
ast 2 out of 3 results of mycological examination
of: stomach contents, surface brushing from the
bottom of the ulcer or gastric mucosa, biopsy
specimen sampled from the ulcer or gastric mu-
cosa. For statistic analysis the mean count of fun-
gal cells in specimens taken from a patient was
used.
b) Patients with gastric ulcer and non-significant
fungal cell count in the stomach in whom at le-
ast one examination result was 103 cells/ml or
lower or no fungi were found.
c) Patients with endoscopic diagnosis of chronic
gastritis, confirmed by histology, with significant
count of fungal cells; criteria as described above.
d) Patients with chronic gastritis and non-significant
fungal cells count.
e) Control group comprising patients with regular
endoscopy of gastric mucosa.
Following a 4-week period of standard antiulcero-
us treatment the above examinations were repe-
ated. Eradication treatment was introduced in ure-
ase-positive patients with endoscopic diagnosis of
gastric ulcer, according to contemporary recom-
mendation. If gastric ulcer was not completely cu-
red, examinations were repeated every 2 weeks
until the ulcer regressed.
Histological examinations
Biopsy specimens sampled from ulcer vicinity or
inflammatory gastric mucosa and prepyloric area
were routinely stained with hematoxylin and eosin
as well as by the PAS or alcian blue — PAS methods
was introduced to assess changes in the tissue and
reveal possible presence of fungi.
The specimens were also stained by the Giemza
modified method for the presence of spiral bacte-
ria. The histological examinations were carried out
in the Institute of Clinical and Experimental Patho-
morphology of Collegium Medicum, Jagiellonian
University, Krakw.
Statistical analysis
The results of our research are presented as mean
values (standard error of the mean – SEM). The
statistical significance of differences between the
studied groups was assessed using c2 test [40]. The
value of p < 0.05 was considered to be statistically
significant.
The variability of the parameters like gastric ulcer
diameter and concentration of fungi in the sto-
mach was analysed by the least squares method
and described by equation: d = Ae—bt, where expo-
nent ÔbÕ determines the rate of changes in the abo-
ve mentioned parameters in subsequent endosco-
pic examinations [12].
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RESULTS
The presence of fungi in the material sampled on
endoscopy, i.e. in stomach contents, surface bru-
shing and biopsy specimen from gastric mucosa in
patients with gastric ulcer and chronic gastritis is
presented in Table 2.
The quantitative mycological examination revealed si-
gnificant fungal cells count in 54.2% of the cases and in
13.8% of the cases the fungal cells count was patholo-
gically significant amounting to 106 cells/ml in the group
of 94 patients with endoscopic diagnosis of gastric
ulcer. The significant count of fungal cells was found in
10.3% of the cases compared with 4.3% in the control
group in the group of 107 patients with chronic gastritis.
In this research work it is attempted to recognize
the differences, or lack of them, between patients
with significant and non-significant fungal cells co-
unt in the clinical course of gastric ulcer disorder.
In the group of gastric ulcer patients with significant
count of fungal cells, the mean duration of the dise-
ase was 9.2 years, whereas in gastric ulcer patients
with non-significant fungal cells count was 5.7 years.
As it is demonstrated in Figure 1, the cases with
duration of the disease exceeding 6 years were
more frequent in the group of gastric ulcer patients
with significant fungal cells count as compared to
the cases of ulcers not colonized by fungi. The ca-
ses with shorter duration of symptoms, not exce-
eding 5 years, were more frequent in gastric ulcer
patients with non-significant fungal cells count.
The frequency of clinical symptoms in gastric ulcer
patients with significant and non-significant count
of fungal cells as found at the moment of diagnosis
is presented in Table 3.
Among the clinical symptoms reported by the pa-
tients with gastric ulcer such as pain in the epiga-
strium, weakness, weight loss, vomiting, retroster-
nal pain, dysphagia — two of them i. e. pain of epi-
gastrium and weight loss were significantly more
frequent in the group of high fungal cells count,
p = 0.039 and p = 0.019, respectively.
With gastric ulcers regression clinical symptoms
subsided. Detailed results are presented in Table 4.
On the basis of the above data it was found that on
week 4 such symptoms as pain in epigastrium, we-
akness, weight loss and vomiting were significantly
more frequent in gastric ulcer patients with signifi-
cant count of fungal cells.
The history data concerning stimulants usage, pre-
sented in Table 5, did not indicate any remarkable
difference between gastric ulcer patients with signi-
ficant and non-significant fungal cells count.
Studied group N Significant
Count of fungal cells
106 cells/ml
Non-significant
I Gastric ulcer
II Chronic gastritis
III Control
The statistical significance: I vs.II p < 0.0001; I vs.III p < 0.00001; II vs.III p = 0.05
94
107
92
51 (54.2%)
11 (10.3%)
4 (4.3%)
13 (13.8%)
2 (1.9%)
0
43 (45.8%)
96 (89.7%)
88 (95.7%)
Table 2. Occurrence of significant count of fungal cells in material taken from the stomach with regard to patient groups
(the absolute and percentage values)
Studied group N Pain inepigastrium Weakness Weight loss Vomiting
Retrosternal
pain Dysphagia
Gastric ulcer with significant fungal cells
count in stomach
Gastric ulcer with non-significant fungal
cells count in stomach
Significance level
NS = statistically non-significant
38
43
92 %
83 %
< 0.05
76 %
68 %
NS
60 %
43 %
< 0.05
31 %
35 %
NS
18 %
29 %
NS
18 %
11 %
NS
Table 3. The frequency of clinical symptoms in gastric ulcer patients with significant and non-significant count of fungal cells as found at diagnosis.
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The localization of gastric ulcers of significant and
non-significant fungal cells count is presented in Fi-
gure 2.
Gastric ulcers with significant fungal cells count we-
re significantly more frequent in the stomach body
compared with ulcers with non-significant fungal
cells count (49% vs 21%, respectively) whereas
ulcers with non-significant fungal cells count were
significantly more frequent in the prepyloric area in
comparison to significant fungal cells count (49% vs
16%, respectively).
On endoscopic detection of gastric ulcers, the dia-
meters of ulcers with high fungal cells count were
significantly larger than the diameters of ulcers with
low fungal cells count (p = 0.01). The mean, mini-
mum and maximum values of ulcers diameters in
the above groups are presented in Table 6.
The frequency of ulcers with non-significant fungal
cells count was threefold much higher than the fre-
quency of ulcers with significant fungal cells count
in the group of gastric ulcers whose diameters ran-
ged from 0 to 10 mm.
Mean value of the ulcer diameter of each studied
group was calculated on consecutive endoscopic
examinations performed at 4, 6, 8, 10 weeks of
observation. Time-related changes in gastric ulcer
diameters were approximated with the least square
method using an exponential function d = Ae-bt
Studied group N Pain inepigastrium Weakness Weight loss Vomiting
Retrosternal
pain Dysphagia
Gastric ulcer with significant fungal cells
count in stomach
Gastric ulcer with non-significant fungal
cells count in stomach
Significance level
NS = statistically non-significant
38
43
92 %
83 %
< 0.05
76 %
68 %
NS
60 %
43 %
< 0.05
31 %
35 %
NS
18 %
29 %
NS
18 %
11 %
NS
Table 4. Regression of clinical symptoms in gastric ulcer patients with significant and non-significant count of fungal cells on week 4 following
diagnosis.
Studied group N Smoking > 20/day Alcohol > 50 g/day Coffee > 3 cups/day
Gastric ulcer with significant fungal
cells count in stomach
Gastric ulcer with non-significant fungal
cells count in stomach
Significance level
NS = statistically non-significant
38
43
47 %
55 %
NS
30 %
26 %
NS
40 %
35 %
NS
Table 5. Frequency of stimulants uptake by the patients with significant and non-significant count of fungal cells in stomach.
Figure 1. Duration of gastric ulcer in patients with significant 
and non-significant fungal cells count.
Figure 2. Location of gastric ulcers with significant and non-significant
fungal cells count.
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[38]. This function was chosen as its character is re-
levant to the real time-dependent variability of
ulcers diameters.
In this function "d" represents ulcer diameter, "t" ti-
me from the start of observation, coefficient "A" re-
flects the shape of the function. The rate of ulcer
regression is determined by exponent "b". The hi-
gher "b" the higher the rate of ulcer diameter re-
duction. All this data is presented by Figure 3.
The obtained results indicate a significantly higher
rate of changes in ulcer diameter in cases with low
fungal cells count as compared to cases with high
fungal cells count. That can be concluded from the
values of exponent "b" in equations of the curves
describing the changes in ulcer diameters during
consecutive endoscopic examinations: 0.4688 and
0.1792 respectively.
The percentage of regressed gastric ulcers found on
consecutive endoscopic follow-up examinations fol-
lowing 4, 6, 8, 10 weeks of observation is presen-
ted in Table 7. Based on this data the rate of regres-
sed gastric ulcers found on consecutive endoscopic
examinations was significantly higher in the group
of ulcers with non-significant fungal cells count.
DISCUSSION
Research works conducted since the late 1970s in-
dicate a substantial role of infectious factor in the
pathogenesis of gastric and duodenal ulcer disease.
Previous concepts that acidic gastric environment
is unfavourable to microbial colonization have not
been confirmed yet [25].
The latest data on the incidence of fungal infec-
tions in gastric ulcers range from 6.5%, according
to di Febo, to 33—36%, according to Katzenstein
and Gotlieb-Jensen [41,42,24]. In our research
work we found significantly more frequent fungal
colonization of gastric ulcers: In 54.2% of patients
compared to 10.3% of patients with chronic gastri-
tis and 4.3% in control group. It is noteworthy that
in 13.8% of all gastric ulcer cases the count of fun-
gal cells was extremely high and amounted to 106
cells/ml. Inconsistency of data reported by different
authors seems to be partially due to a set of diffe-
rent criteria employed for detecting fungal coloni-
zation, age of patients, concurrent diseases and ap-
plied pharmacotherapy.
Wyatt et al. reported that the incidence of spiral
bacteria is dependent on the age of patients. In the
group of patients below 60 years of age these bac-
teria were found in 91.1% of patients whereas in
the group over 70 years of age — in 65.5% [43].
The incidence of spiral bacteria found in our con-
trol group (67%) is similar to that reported by Asa-
ke: 40—70% of functional dyspepsia cases and 50%
in healthy subjects [44]. Polish authors, including
Muszy˜ski et al, report the following frequency of
Gastric ulcers The diameters of gastriculcers [mm]
with significant count of fungal cells
with non-significant count of fungal cells
The mean (SEM, minimum and maximum values are presented.
15–2.3  10—40
12–1.5  5—20
Table 6. The diameters of gastric ulcers with significant
and non-significant count of fungal cells.
Gastric ulcers N
4 6 8 10 12
Week of follow-up examination 
with significant count of fungal cells
with non-significant count of fungal cells
Significance level
NS = statistically non-significant
20
43
62 %
78 %
< 0.05
70 %
92 %
< 0.005
79 %
95 %
< 0.005
84 %
97 %
< 0.05
89 %
98 %
< 0.05
Table 7. The rate of healed gastric ulcers in consecutive endoscopic examinations in gastric ulcer patients with significant
and non-significant fungal cells count.
Figure 3. Changes in gastric ulcers diameters in patients with non-
significant and significant fungal cells count as measured on
consecutive endoscopies.
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H. pylori: 62% in functional dyspepsia cases,
65—97% in gastric ulcer patients and 20—38% in
healthy persons [45]. In our study the coincidence
of significant fungal cells count with the occurrence
of spiral bacteria was found in 14% of gastric ulcer
cases, in 4% of chronic gastritis cases and in 2% of
control group subjects. These data are similar to
those reported by Kalogeropuolus et al. Twelve
percent for gastric ulcers could indicate a rare co-
existence of spiral bacteria with fungi what can re-
sult from different environmental conditions requ-
ired for their colonization and growth [30].
Some differences between gastric ulcer patients
with significant and non-significant count of fungal
cells in the stomach have been observed during
the study. The mean duration of gastric ulcer disor-
der in patients with significant fungal cells count
was twice as much as in patients with non-signifi-
cant fungal cells count: 9.2 and 5.7 years respecti-
vely. In the group with high fungal cells count the
cases over 6 years were significantly more frequent
as compared with the group with non-significant
fungal cells count.
Among the clinical symptoms reported by patients
with gastric ulcer, like pain of epigastrium, weak-
ness, weight loss, vomiting, retrosternal pain, dys-
phagia — pain of epigastrium and weight loss were
significantly more frequent in patients with high
fungal cells count.
Following 4 weeks of observation the symptoms li-
ke pain of epigastrium, weakness, weight loss and
vomiting remained significantly more frequent in
gastric ulcer patients with high fungal cells count.
The medical history data on stimulants use in pa-
tients did not reveal any significant differences be-
tween gastric ulcer patients with significant and
non-significant fungal cells count.
Examination of gastric ulcers position showed that
ulcers with significant fungal cells count were more
frequently encountered in the body of stomach in
comparison with ulcers with non-significant fungal
cells count (Fig. 2). Ulcers with low count of fungal
cells were significantly more frequently observed in
the prepyloric area as compared with ulcers with
significant fungal cells count. Loffeld et al. and
Oehlert et al. reported similar results [23,46]. This
phenomenon can be explained by predisposing
conditions to fungal colonization observed in the
stomach body such as enhanced mucosal atrophy
in this region in the course of gastric ulcer disorder
and higher pH compared with the prepyloric area.
The diameters of ulcers with high fungal cells count
were significantly larger as compared with those of
ulcers with low fungal cells count. Other authors,
e.g. Loffeld et al. report that gastric ulcers with high
fungal cells count are large in size, have infiltrated
margins and resemble neoplastic lesions [23].
In our research work it was attempted to evaluate
the effect of fungal colonization on the course of
ulcer niche regression. On the basis of the obta-
ined results it was found that the rate of gastric
ulcer size reduction was significantly higher in pa-
tients with low fungal cells count than in patients
with high count of fungal cells. That observation is
proved by the exponents in the equations of the
curves demonstrating changes in gastric ulcers dia-
meters of a given group in consecutive endoscopic
examinations.
The rate of regressed ulcers measured on consecuti-
ve endoscopic examinations was significantly higher
in the group with non-significant fungal cells count.
The fungal colonization of the stomach was found
in 54.2% of patients with diagnosis of gastric ulcer
confirmed by endoscopy. In these patients signifi-
cant count of fungal cells without concurrent pre-
sence of spiral bacteria accounted for 40%.
The above data are in agreement with those of Kat-
zenstein and Gotlieb-Jensen who reported signifi-
cantly increased fungal cells count in 33—36% of
gastric ulcers cases [42,24]. Fungal colonization of
gastric ulcers in patients enrolled in this study was
the most likely to be the secondary one, despite re-
ports on primary nature of fungal infection leading
to gastric mucosa ulceration development [46].
That assumption could be supported by the lack of
a correlation between significant fungal coloniza-
tion of the stomach and significant titres of antifun-
gal antibodies and fungal antigens in the blood of
the patients. Furthermore, only 2 patients with ga-
stric ulcer were found to have fungal infiltrations in
biopsy specimens from gastric mucosa.
In gastric ulcer patients with high fungal cells count
a longer duration of the clinical symptoms that wor-
sened life quality such as weakness, pain in epiga-
strium, weight loss and vomiting were observed.
CONCLUSIONS
1. Gastric mucosa and gastric contents are often
areas of fungal colonization. Fungi are found in
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54.2% of gastric ulcers cases and in 10.3% of
chronic gastritis cases.
2. Fungal colonization of gastric ulcers prolongs the
healing process. Moreover, it leads to clinical
symptoms maintenance longer as compared to
ulcers with non-significant fungal cells count.
3. In gastric ulcer patients with high count of fungal
cells this count remains significantly high despite
ulcer regression. This fact could be in favour of
the concept of individual susceptibility of gastric
mucosa to fungal colonization.
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